2022 Q4 Form 10-Q Financial Statement
#000149315222030819 Filed on November 07, 2022
Income Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $1.575M | $1.443M | $1.184M |
YoY Change | 16.73% | 21.82% | 7.68% |
% of Gross Profit | |||
Research & Development | $2.252M | $702.3K | $2.964M |
YoY Change | 4.13% | -76.31% | 394.07% |
% of Gross Profit | |||
Depreciation & Amortization | $2.760K | $2.950K | $1.850K |
YoY Change | 38.69% | 59.46% | |
% of Gross Profit | |||
Operating Expenses | $3.826M | $2.145M | $4.149M |
YoY Change | 8.97% | -48.29% | 144.05% |
Operating Profit | -$2.145M | -$4.149M | |
YoY Change | -48.29% | ||
Interest Expense | $74.68K | $52.22K | $77.22K |
YoY Change | -366.43% | -32.38% | |
% of Operating Profit | |||
Other Income/Expense, Net | $370.5K | -$171.6K | $17.68K |
YoY Change | -1070.86% | ||
Pretax Income | -$3.381M | -$2.265M | -$4.054M |
YoY Change | -4.5% | -44.14% | 138.47% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$3.381M | -$2.265M | -$4.054M |
YoY Change | -4.5% | -44.14% | 138.47% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.21 | -$0.36 | |
Diluted Earnings Per Share | -$0.31 | -$208.9K | -$362.4K |
COMMON SHARES | |||
Basic Shares Outstanding | 10.86M shares | 10.83M shares | 11.19M shares |
Diluted Shares Outstanding | 10.84M shares |
Balance Sheet
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $55.20M | $57.83M | $73.83M |
YoY Change | -21.96% | -21.68% | 254.96% |
Cash & Equivalents | $37.20M | $39.26M | $54.67M |
Short-Term Investments | $17.99M | $18.57M | $19.16M |
Other Short-Term Assets | $3.527M | $4.193M | $2.504M |
YoY Change | 77.13% | 67.45% | 49.95% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $58.72M | $62.02M | $76.34M |
YoY Change | -19.24% | -18.75% | 239.58% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $48.01K | $43.81K | $251.7K |
YoY Change | 58.73% | -82.59% | 1158.35% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $17.89K | $17.89K | $1.018M |
YoY Change | 0.0% | -98.24% | |
Total Long-Term Assets | $113.6K | $144.6K | $1.270M |
YoY Change | -90.8% | -88.61% | 12595.6% |
TOTAL ASSETS | |||
Total Short-Term Assets | $58.72M | $62.02M | $76.34M |
Total Long-Term Assets | $113.6K | $144.6K | $1.270M |
Total Assets | $58.84M | $62.16M | $77.61M |
YoY Change | -20.44% | -19.9% | 245.07% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.745M | $3.047M | $1.637M |
YoY Change | 26.28% | 86.17% | 102.05% |
Accrued Expenses | $52.89K | $92.02K | $149.0K |
YoY Change | -65.22% | -38.23% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.798M | $3.139M | $1.786M |
YoY Change | 20.3% | 75.79% | 120.44% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $0.00 | $0.00 | $92.02K |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $0.00 | $0.00 | $92.02K |
YoY Change | -100.0% | -100.0% | -16.35% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.798M | $3.139M | $1.786M |
Total Long-Term Liabilities | $0.00 | $0.00 | $92.02K |
Total Liabilities | $2.798M | $3.139M | $1.878M |
YoY Change | 17.62% | 67.18% | 104.09% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$39.28M | -$35.90M | |
YoY Change | 56.99% | ||
Common Stock | $1.086K | $1.086K | |
YoY Change | -2.07% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $56.04M | $59.03M | $75.73M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $58.84M | $62.16M | $77.61M |
YoY Change | -20.44% | -19.9% | 245.07% |
Cashflow Statement
Concept | 2022 Q4 | 2022 Q3 | 2021 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$3.381M | -$2.265M | -$4.054M |
YoY Change | -4.5% | -44.14% | 138.47% |
Depreciation, Depletion And Amortization | $2.760K | $2.950K | $1.850K |
YoY Change | 38.69% | 59.46% | |
Cash From Operating Activities | -$2.669M | -$4.038M | -$4.683M |
YoY Change | 30.89% | -13.76% | 62.03% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $6.950K | -$6.710K | -$3.490K |
YoY Change | 92.26% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $609.8K | -$67.65K | -$999.0K |
YoY Change | -360.65% | -93.23% | |
Cash From Investing Activities | $602.9K | -$74.36K | -$1.003M |
YoY Change | -357.68% | -92.58% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 0.000 | 0.000 |
YoY Change | -100.0% | -100.0% | |
NET CHANGE | |||
Cash From Operating Activities | -2.669M | -4.038M | -4.683M |
Cash From Investing Activities | 602.9K | -74.36K | -1.003M |
Cash From Financing Activities | 0.000 | 0.000 | 0.000 |
Net Change In Cash | -2.066M | -4.113M | -5.685M |
YoY Change | -34.32% | -27.66% | 90.14% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.669M | -$4.038M | -$4.683M |
Capital Expenditures | $6.950K | -$6.710K | -$3.490K |
Free Cash Flow | -$2.676M | -$4.032M | -$4.679M |
YoY Change | 31.23% | -13.84% | 61.91% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1099792 | shares | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
30245 | usd |
CY2022Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
82918 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
185943 | usd |
CY2021Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
1000000 | usd |
CY2022Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
17889 | usd |
CY2021Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
17889 | usd |
CY2022Q3 | us-gaap |
Assets
Assets
|
62164380 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
73950477 | usd |
CY2022Q3 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
3046972 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
2174109 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
92023 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
152058 | usd |
CY2022Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
3138995 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2326167 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
52890 | usd |
CY2022Q3 | us-gaap |
Liabilities
Liabilities
|
3138995 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
2379057 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
1000000 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001763950 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2021Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
usd | |
CY2022Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
usd | |
CY2022Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
usd | |
CY2022Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
usd | |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
usd | ||
CY2021Q2 | LTRN |
Stock Issued During Period Value Common Stock Issued From Warrant And Option Exercises
StockIssuedDuringPeriodValueCommonStockIssuedFromWarrantAndOptionExercises
|
usd | |
CY2021Q3 | LTRN |
Stock Issued During Period Value Common Stock Issued From Warrant And Option Exercises
StockIssuedDuringPeriodValueCommonStockIssuedFromWarrantAndOptionExercises
|
usd | |
CY2022Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
usd | |
us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
usd | ||
LTRN |
Gain On Loan Forgiveness
GainOnLoanForgiveness
|
usd | ||
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
usd | ||
CY2021Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
usd | ||
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
usd | ||
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
usd | ||
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
usd | ||
LTRN |
Proceeds From Issuance Of Common And Preferred Stock
ProceedsFromIssuanceOfCommonAndPreferredStock
|
usd | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
usd | ||
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
usd | ||
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
usd | ||
LTRN |
Application Of Deferred Offering Costs To Public Offering Proceeds
ApplicationOfDeferredOfferingCostsToPublicOfferingProceeds
|
usd | ||
CY2022Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
usd | |
CY2022Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
1990953 | usd |
CY2022Q3 | us-gaap |
Assets Current
AssetsCurrent
|
62019760 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
72716400 | usd |
CY2022Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
43813 | usd |
dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Lantern Pharma Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity File Number
EntityFileNumber
|
001-39318 | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
46-3973463 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
1920 McKinney Avenue | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
7th Floor | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Dallas | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
TX | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
75201 | ||
dei |
City Area Code
CityAreaCode
|
(972) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
277-1136 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, $0.0001 par value | ||
dei |
Trading Symbol
TradingSymbol
|
LTRN | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
true | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2022Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
10857040 | shares |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
39257887 | usd |
CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
51524295 | usd |
CY2022Q3 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
541180 | usd |
CY2022Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
18568725 | usd |
CY2021Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
19201152 | usd |
CY2022Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3651968 | usd |
CY2022Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2022Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2021Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10857040 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10857040 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
11088835 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
11088835 | shares |
CY2022Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
1086 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1109 | usd |
CY2022Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
95361099 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
96685924 | usd |
CY2022Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-435035 | usd |
CY2021Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-92689 | usd |
CY2022Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-35901765 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-25022924 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59025385 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
71571420 | usd |
CY2022Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
62164380 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
73950477 | usd |
CY2022Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1442961 | usd |
CY2021Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1184486 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
4255119 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3671945 | usd | |
CY2022Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
702296 | usd |
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2964391 | usd |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
6351356 | usd | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
5408320 | usd | |
CY2022Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2145257 | usd |
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
4148877 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
10606475 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
9080265 | usd | |
CY2022Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2145257 | usd |
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4148877 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-10606475 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-9080265 | usd | |
CY2022Q3 | us-gaap |
Interest Income Other
InterestIncomeOther
|
52224 | usd |
CY2021Q3 | us-gaap |
Interest Income Other
InterestIncomeOther
|
77219 | usd |
us-gaap |
Interest Income Other
InterestIncomeOther
|
129671 | usd | |
us-gaap |
Interest Income Other
InterestIncomeOther
|
125108 | usd | |
CY2022Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-171648 | usd |
CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
17679 | usd |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-402037 | usd | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
132402 | usd | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2264681 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4053979 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10878841 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8822755 | usd | |
CY2022Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.21 | |
CY2021Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.36 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.00 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.82 | ||
CY2022Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10838888 | shares |
CY2021Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
11186259 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10848402 | shares | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10818201 | shares | |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2264681 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4053979 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10878841 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8822755 | usd | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-118572 | usd |
CY2021Q3 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-55124 | usd |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-394843 | usd | |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
-102689 | usd | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
32018 | usd |
us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
52497 | usd | |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-86554 | usd |
CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-55124 | usd |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-342346 | usd | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-102689 | usd | |
CY2022Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-2351236 | usd |
CY2021Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-4109103 | usd |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-11221187 | usd | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-8925444 | usd | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
19698795 | usd |
CY2021Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
64166854 | usd |
CY2021Q1 | LTRN |
Stock Issued During Period Value Common Stock Issued From Warrant And Option Exercises
StockIssuedDuringPeriodValueCommonStockIssuedFromWarrantAndOptionExercises
|
72753 | usd |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
245519 | usd |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2452295 | usd |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
81731626 | usd |
CY2021Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
245684 | usd |
CY2021Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2316481 | usd |
CY2021Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-47565 | usd |
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
79613264 | usd |
CY2021Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
224413 | usd |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4053979 | usd |
CY2021Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-55124 | usd |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
75728574 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
71571420 | usd |
CY2022Q1 | LTRN |
Stock Issued During Period Value Common Stock Issued From Warrant And Option Exercises
StockIssuedDuringPeriodValueCommonStockIssuedFromWarrantAndOptionExercises
|
299788 | usd |
CY2022Q1 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
267004 | usd |
CY2022Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
2482286 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4121774 | usd |
CY2022Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-218780 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
65315372 | usd |
CY2022Q2 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
289533 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4492386 | usd |
CY2022Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-37012 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
61075507 | usd |
CY2022Q3 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
301113 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2264681 | usd |
CY2022Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-86554 | usd |
CY2022Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
59025385 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10878841 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8822755 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
7321 | usd | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
4770 | usd | |
LTRN |
Noncash Lease Adjustments
NoncashLeaseAdjustments
|
108451 | usd | |
LTRN |
Noncash Lease Adjustments
NoncashLeaseAdjustments
|
21553 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
857650 | usd | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
715616 | usd | |
us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
87211 | usd | |
LTRN |
Gain On Loan Forgiveness
GainOnLoanForgiveness
|
109223 | usd | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-158703 | usd | |
us-gaap |
Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
|
-76326 | usd | |
us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-476751 | usd | |
us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
-14908 | usd | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
1759848 | usd | |
us-gaap |
Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
|
493647 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
885998 | usd | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
134152 | usd | |
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-118351 | usd | |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
17889 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-10098629 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-8552515 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
20889 | usd | |
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
15498 | usd | |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
3322386 | usd | |
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
19281130 | usd | |
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
2919682 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-423593 | usd | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-19296628 | usd | |
LTRN |
Proceeds From Issuance Of Common And Preferred Stock
ProceedsFromIssuanceOfCommonAndPreferredStock
|
68999994 | usd | |
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
4783816 | usd | |
us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
2482286 | usd | |
LTRN |
Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
|
299788 | usd | |
LTRN |
Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
|
72753 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-2182498 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
64288931 | usd | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
-20508 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-12725228 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
36439788 | usd | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
52524295 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
19229232 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
39799067 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
55669020 | usd |
CY2022Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
39257887 | usd |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
54669020 | usd |
CY2022Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
541180 | usd |
CY2021Q3 | us-gaap |
Restricted Cash
RestrictedCash
|
1000000 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
39799067 | usd |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
55669020 | usd |
LTRN |
Application Of Deferred Offering Costs To Public Offering Proceeds
ApplicationOfDeferredOfferingCostsToPublicOfferingProceeds
|
-49324 | usd | |
us-gaap |
Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
|
-394843 | usd | |
us-gaap |
Debt Securities Unrealized Gain Loss
DebtSecuritiesUnrealizedGainLoss
|
-102689 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-10879000 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-8823000 | usd | |
CY2022Q3 | LTRN |
Working Capital
WorkingCapital
|
58881000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_840_eus-gaap--UseOfEstimates_zYDQmMH4Uqge" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates and Assumptions</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The significant areas of estimation include determining research and development accruals and the inputs in determining the fair value of equity-based awards and warrants issued. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_z3OxCGINEzuc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Risks and Uncertainties</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. Operations are subject to significant risk and uncertainties including financial, operational, technological, regulatory, and other risks, including the potential risk of business failure.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The extent of the impact and effects of the coronavirus (COVID-19) on the operation and financial performance of the Company’s business will depend on future developments, including the duration and spread of the outbreak and varying virus mutations, related travel advisories and restrictions, the recovery time of disrupted research services, the consequential staff shortages, and research and development delays, or the uncertainty with respect to the accessibility of additional liquidity or capital markets, all of which are highly uncertain and cannot be predicted. If the Company’s operations are impacted by the outbreak for an extended period, the Company’s results of operations or liquidity may be materially adversely affected.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> | ||
CY2022Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3652000 | usd |
CY2022Q3 | LTRN |
Upfront Payments For Contractor Fees Academic Research Studies And Services And Subscriptions
UpfrontPaymentsForContractorFeesAcademicResearchStudiesAndServicesAndSubscriptions
|
2304000 | usd |
CY2022Q3 | LTRN |
Intellectual Property Related Licensing And Other Fees
IntellectualPropertyRelatedLicensingAndOtherFees
|
281000 | usd |
CY2022Q3 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
762000 | usd |
CY2022Q3 | us-gaap |
Interest Receivable
InterestReceivable
|
305000 | usd |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
3.13 | |
CY2022Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10857040 | shares |
CY2022Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10857040 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
11088835 | shares |
CY2022Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
30000 | usd |
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
108000 | usd | |
CY2021Q3 | us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
38000 | usd |
us-gaap |
Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
|
67000 | usd | |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
11088835 | shares |
CY2022Q3 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
177998 | shares |
CY2021Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
273777 | shares |
CY2022Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
82918 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
185943 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
92023 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
152058 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
52890 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
92023 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
204948 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
40052 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
53403 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
93455 | usd |
CY2022Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
1432 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
92023 | usd |
CY2022Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
92023 | usd |
LTRN |
Lease Expiration Date
LeaseExpirationDate
|
The leases expire in April 2023 | ||
CY2022Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P0Y6M29D | |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y6M29D | |
CY2022Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0465 | pure |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0465 | pure |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
61000 | usd | |
us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
300000 | usd | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
890826 | shares |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.54 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
155000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.79 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
32538 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.03 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
12335 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
13.79 | ||
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1000953 | shares |
CY2022Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
6.52 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
22238 | shares | |
CY2022Q3 | us-gaap |
Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value
AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue
|
4669099 | usd |
CY2022Q3 | LTRN |
Available For Sale Securities Debt Maturities Rolling Year One Through Two Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearOneThroughTwoFairValue
|
6700963 | usd |
CY2022Q3 | us-gaap |
Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue
|
1730113 | usd |
CY2022Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
13100175 | usd |
CY2022Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
|
4622180 | usd |
CY2022Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
258865 | usd |
CY2022Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
|
13201330 | usd |
CY2022Q3 | us-gaap |
Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
786237 | usd |
CY2022Q3 | us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
900000 | usd |
us-gaap |
Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
|
2570000 | usd | |
CY2022Q3 | us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
27000 | usd |
us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
76000 | usd | |
us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
|
18568725 | usd | |
CY2020Q2 | us-gaap |
Proceeds From Loan Originations1
ProceedsFromLoanOriginations1
|
108500 | usd |
CY2020Q2 | us-gaap |
Debt Instrument Description
DebtInstrumentDescription
|
the PPP Loan bore interest at a fixed rate of one percent (1.0%) per annum. Payments of principal and interest were deferred for the first six months following the Origination Date, and the PPP Loan provided that it would mature two years after the Origination Date. The guidance under the Paycheck Protection Program was later updated so that payments of principal and interest were extended past the current fiscal year and maturity was extended past two years. | |
CY2020Q2 | us-gaap |
Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
|
0.010 | pure |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1178951 | shares |